🚨 BREAKTHROUGH: 25-year-old Argentinian biologist Pilar Ferrer has developed an injectable gel that helps repair damaged heart tissue after a heart attack
August 12, 2026 at 3:11 PM
🚨 BREAKTHROUGH: 25-year-old Argentinian biologist Pilar Ferrer has developed an injectable gel that helps repair damaged heart tissue after a heart attack
🚨 BREAKTHROUGH: 25-year-old Argentinian biologist Pilar Ferrer has developed an injectable gel that helps repair damaged heart tissue after a heart attack
September 11, 2026 at 2:44 PM
🚨 BREAKTHROUGH: 25-year-old Argentinian biologist Pilar Ferrer has developed an injectable gel that helps repair damaged heart tissue after a heart attack
Alice Augusta Ball (1892–1916) was a pioneering African American chemist who, at 23, developed the first effective, injectable treatment for leprosy (Hansen’s disease) in 1915 while at the University of Hawaiʻi. Her method, which made chaulmoogra oil soluble and injectable,
March 29, 2026 at 1:23 PM
Alice Augusta Ball (1892–1916) was a pioneering African American chemist who, at 23, developed the first effective, injectable treatment for leprosy (Hansen’s disease) in 1915 while at the University of Hawaiʻi. Her method, which made chaulmoogra oil soluble and injectable,
That's the title that Science magazine is bestowing upon the medication called lenacapavir — a twice yearly injectable that prevents infection by the HIV virus.
That's the title that Science magazine is bestowing upon the medication called lenacapavir — a twice yearly injectable that prevents infection by the HIV virus.
It's under the brand name 'Yeztugo,' and it has a 100% success rate in women and a 96% success rate in men even after a year - which means that it's far more forgiving of a weird schedule, and still highly effective if you delay your booster.
It's under the brand name 'Yeztugo,' and it has a 100% success rate in women and a 96% success rate in men even after a year - which means that it's far more forgiving of a weird schedule, and still highly effective if you delay your booster.
In June, the Food and Drug Administration approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show prevents new infections.
July 28, 2025 at 1:14 AM
In June, the Food and Drug Administration approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show prevents new infections.
once you begin going through the steps of acquiring injectable hrt you'll never want to stop beating the healthcare system to death with your bare hands
August 17, 2026 at 4:10 AM
once you begin going through the steps of acquiring injectable hrt you'll never want to stop beating the healthcare system to death with your bare hands